Test directory: Vedolizumab Rflx to Vedolizumab Ab

Ordering Code7783
Test NameVedolizumab Rflx to Vedolizumab Ab
AliasVedolizumab Quantitation with Rflx to Antibodies, Serum
Vedolizumab
VEDO
Entyvio
Preferred SpecimenSerum
Preferred ContainerPlain (Red)
Other Specimen/ContainerSerum in SST (Gold)
Optimum Volume1.5 mL
Collection InstructionsFor 12 hours before specimen collection do not take multivitamins or dietary supplements containing biotin (vitamin B7), which is commonly found in hair, skin, and nail supplements and multivitamins

Nivolumab (Opdivo) must be discontinued at least 4 weeks prior to testing for Vedolizumab quantitation in serum

When Vedolizumab result is 15.0 mcg/mL or less, then testing for antibodies to Vedolizumab will be performed.
Handling InstructionsDraw blood immediately before next scheduled dose (trough specimen).
Transport RequirementsOahu: Refrigerated
Airline: Refrigerated
Specimen StabilityAmbient: Not Stable
Refrigerated: 28 Days
Frozen: 28 Days
Avail. StatNO
Analytic Time10 Days
MethodologyLiquid Chromatography-Mass Spectrometry (LC-MS/MS)
Reference Lab Mayo Medical Lab

Reference range(s)

The reference ranges listed below are valid on this date of December 3, 2024.
ComponentAgeMale NormMale Critical LowMale Critical HighFemale NormFemale Critical HighFemale Critical LowUnitsAdd'l info
Vedolizumab QNALLmcg/mL

For...
For concentrations of Vedolizumab less than or equal to 15.0 mcg/mL, reflex testing for antibodies-to-Vedolizumab will be performed

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug
Administration

See report.
Note1

Note1:


For concentrations of Vedolizumab less than or equal to 15.0 mcg/mL, reflex testing for antibodies-to-Vedolizumab will be performed

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the U.S. Food and Drug
Administration

See report..